Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.
- DOI
- 10.1016/j.jaip.2026.04.010
- Published
- 2026 Jul
- Container
- The journal of allergy and clinical immunology. In practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaip.2026.04.010,
title = {Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.},
author = {Wechsler ME and Bourdin A and Rabe KF and Pavord ID and Virchow JC and Katial R and Israel E and Xia C and Ledanois O and Soliman M and Jackson DJ},
year = {2026},
journal = {The journal of allergy and clinical immunology. In practice},
doi = {10.1016/j.jaip.2026.04.010},
url = {https://doi.org/10.1016/j.jaip.2026.04.010}
}RIS
TY - JOUR TI - Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis. AU - Wechsler ME AU - Bourdin A AU - Rabe KF AU - Pavord ID AU - Virchow JC AU - Katial R AU - Israel E AU - Xia C AU - Ledanois O AU - Soliman M AU - Jackson DJ PY - 2026 JO - The journal of allergy and clinical immunology. In practice DO - 10.1016/j.jaip.2026.04.010 UR - https://doi.org/10.1016/j.jaip.2026.04.010 ER -
APA
ME, W., A, B., KF, R., ID, P., JC, V., R, K., E, I., C, X., O, L., M, S., & DJ, J. (2026). Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2026.04.010
Source records
- pubmed · retrieved 2026-09-27T10:45:02.117Z